Results 91 to 100 of about 838,163 (294)

Significance of covariates.

open access: yes, 2014
The table gives an overview between covariates and the three outcome measures: VAS and ODI. Covariates with a p value≤0.1 were included in the final model.Significance of covariates.
Cecilie Røe (627915)   +4 more
core   +1 more source

Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons   +33 more
wiley   +1 more source

A study of partial F tests for multiple linear regression models [PDF]

open access: yes, 2007
Partial F tests play a central role in model selections in multiple linear regression models. This paper studies the partial F tests from the view point of simultaneous confidence bands.
Liu, Wei, Jamshidian, Mortaza
core   +2 more sources

IDENTIFICATION OF COVARIANCE STRUCTURES [PDF]

open access: yesEconometric Theory, 2006
Summary: The issue of identification of covariance structures, which arises in a number of different contexts, has been so far linked to conditions on the true parameters to be estimated. In this paper, this limitation is removed. As done by \textit{S. Johansen} [J. Econom. 69, No.
openaire   +1 more source

Semiparametric Estimation with Generated Covariates [PDF]

open access: yes
In this paper, we study a general class of semiparametric optimization estimators of a vector-valued parameter. The criterion function depends on two types of infinite-dimensional nuisance parameters: a conditional expectation function that has been ...
Schienle, Melanie   +2 more
core  

Description of other covariates.

open access: yes, 2021
Description of other covariates.
Syed Afroz Keramat (8900420)   +7 more
core   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio   +8 more
wiley   +1 more source

Integration of Time‐Varying Pharmacometric Modeling With Cox Regression for Time‐to‐Event Analysis in NONMEM

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Although time‐varying Cox regression modeling approaches have been developed, exposure–response analyses for time‐to‐event (TTE) endpoints often rely on static exposure covariates and may overlook the real‐world dosing variability and drug concentration ...
Chih‐Wei Lin   +3 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer

open access: yesClinical and Translational Science
Capivasertib is a potent, selective pan‐AKT inhibitor. In the Phase III CAPItello‐291 trial in patients with aromatase inhibitor‐resistant, hormone receptor (HR)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative advanced breast cancer ...
Carlos Fernandez Teruel   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy